The peptide boom is real - and messy
Every other brand launching in 2026 seems to have peptides as a hero ingredient. Matrixyl, Argireline, copper peptides, signal peptides - the language is everywhere. And for good reason: consumer search volume for "peptide skincare" is up 340% year-on-year.
But here's what most brands are getting wrong: they're treating peptides like a checkbox. Throw in three peptides, slap "multi-peptide complex" on the label, and call it innovation.
That's not innovation. That's ingredient stuffing. And consumers are getting smarter.
What consumers actually want
The shift we're seeing across our client base is this: consumers don't want more ingredients. They want clearer stories about fewer ingredients.
They want to understand what one peptide does and why it matters for their specific concern. Not a laundry list of five peptides with no explanation of how they work together.
The brands winning right now are the ones that:
- Pick one hero peptide and build the entire product narrative around it
- Explain the mechanism of action in plain language (not in clinical jargon)
- Show before-and-after evidence or clinical trial results
- Position the peptide within a routine context, not in isolation
The formulation challenge brands underestimate
Peptide stability is genuinely difficult. Copper peptides degrade in the wrong pH environment. Signal peptides need specific delivery systems to actually penetrate. Most contract manufacturers will happily formulate a "peptide serum" at concentrations too low to have any meaningful effect, and you'll never know unless you ask the right questions.
Questions to ask your formulator:
- What is the minimum effective concentration for this peptide, and are we at or above it?
- What is the stability profile across our target shelf life?
- How does this peptide interact with the other active ingredients in the formula?
- Is there clinical evidence for this specific peptide at this concentration?
If your formulator can't answer these clearly, that's a red flag.
The regulatory angle
Claims around peptides are getting tighter. The EU Commission has been increasingly scrutinising "botox-like" and "anti-wrinkle" claims linked to peptide products. If you're positioning a topical peptide as a replacement for injectables - even implicitly - you need robust evidence or you're exposed.
Safe positioning: focus on skin texture, firmness, and hydration benefits. Avoid any comparison to medical procedures, even casually in marketing copy.
What this means for your brand
If you're formulating with peptides, be honest with yourself about whether you're leading with science or with buzzwords. The market is saturated enough that "contains peptides" is no longer a differentiator. The differentiator is clarity: one peptide, one story, one proof point.
The brands that will still be winning in 2027 are the ones investing in the science now, not just the label claims.